INOZYME PHARMA, INC. Share-based Payment Arrangement, Expense
INOZYME PHARMA, INC. reported Share-based Payment Arrangement, Expense of $1.86 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-14
- INOZYME PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $1.86M, a 9.82% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $1.97M, a 17.74% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $2.13M, a 27.15% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $2.16M, a 34.81% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for fiscal 2024 was $7.95M, a 12.90% increase from fiscal 2023.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for fiscal 2023 was $7.04M, a 8.61% decline from fiscal 2022.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for fiscal 2022 was $7.70M, a 6.94% increase from fiscal 2021.
- INOZYME PHARMA, INC. share-based payment arrangement, expense for fiscal 2021 was $7.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-14 | $3.83M derived: sum of 2 quarters · filed 2025-05-14 | $5.95M derived: sum of 3 quarters · filed 2025-05-14 | $8.11M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $4.10M derived: sum of 2 quarters · filed 2025-03-10 | $6.25M derived: sum of 3 quarters · filed 2025-03-10 | $7.95M 10-K · filed 2025-03-10 | |
| 2024-09-30 | $2.13M 10-Q · filed 2024-11-05 | $4.28M derived: sum of 2 quarters · filed 2024-11-05 | $5.97M 10-Q · filed 2024-11-05 | $7.65M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-06-30 | $2.16M 10-Q · filed 2024-08-06 | $3.85M 10-Q · filed 2024-08-06 | $5.52M derived: sum of 3 quarters · filed 2025-05-14 | $7.19M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-14 | $3.37M derived: sum of 2 quarters · filed 2025-05-14 | $5.04M derived: sum of 3 quarters · filed 2025-05-14 | $6.64M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $3.35M derived: sum of 2 quarters · filed 2025-03-10 | $4.95M derived: sum of 3 quarters · filed 2025-03-10 | $7.04M 10-K · filed 2025-03-10 | $7.00M 10-K · filed 2024-03-12 |
| 2023-09-30 | $1.67M 10-Q · filed 2024-11-05 | $3.27M derived: sum of 2 quarters · filed 2024-11-05 | $5.36M 10-Q · filed 2024-11-05 | $7.28M derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-06 | $3.69M 10-Q · filed 2024-08-06 | $5.61M derived: sum of 3 quarters · filed 2024-08-06 | $7.46M derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $2.09M 10-Q · filed 2024-05-07 | $4.01M derived: sum of 2 quarters · filed 2024-05-07 | $5.86M derived: sum of 3 quarters · filed 2024-05-07 | $8.04M derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $3.76M derived: sum of 2 quarters · filed 2024-03-12 | $5.95M derived: sum of 3 quarters · filed 2024-03-12 | $7.70M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $1.85M 10-Q · filed 2023-11-07 | $4.03M derived: sum of 2 quarters · filed 2023-11-07 | $5.79M 10-Q · filed 2023-11-07 | $7.84M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $2.19M 10-Q · filed 2023-08-08 | $3.94M 10-Q · filed 2023-08-08 | $6.00M derived: sum of 3 quarters · filed 2023-08-08 | $7.75M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $1.75M 10-Q · filed 2023-05-09 | $3.81M derived: sum of 2 quarters · filed 2023-05-09 | $5.56M derived: sum of 3 quarters · filed 2023-05-09 | $7.38M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.81M derived: sum of 2 quarters · filed 2023-03-22 | $5.62M derived: sum of 3 quarters · filed 2023-03-22 | $7.20M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $1.75M 10-Q · filed 2022-11-10 | $3.56M derived: sum of 2 quarters · filed 2022-11-10 | $5.14M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $1.81M 10-Q · filed 2022-08-15 | $3.39M 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-10 | ||||
| 2020-09-30 | $786.00K 10-Q · filed 2021-11-09 | $906.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.03M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $120.00K 10-Q · filed 2021-08-11 | $249.00K 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $129.00K 10-Q · filed 2021-05-12 | ||||
| 2019-09-30 | $107.00K 10-Q · filed 2020-11-12 | $147.00K derived: sum of 2 quarters · filed 2020-11-12 | $188.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $40.00K 10-Q · filed 2020-09-03 | $81.00K 10-Q · filed 2020-09-03 |